Table 1 Demographic and HIV-related characteristics of people living with HIV
From: Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV
Characteristics | PLWH (n = 30) |
|---|---|
Age, years [median (IQR)] | 51 (42–55) |
Sex [n (%)] | |
Male | 27 (90) |
Female | 3 (10) |
Ethnicity [n (%)] | |
Caucasian | 26 (86.7) |
Latin | 2 (6.7) |
African | 1 (3.3) |
Asian | 1 (3.3) |
Epidemiology [n (%)] | |
MSM | 16 (53.3) |
MSW | 6 (20) |
WSM | 3 (10) |
IDU | 3 (10) |
Unknown | 2 (6.7) |
Comorbidities [n (%)] | |
None | 6 (20) |
Hypertension | 10 (33.3) |
Ischemic heart disease | 1 (3.3) |
Non-ischemic heart disease | 1 (3.3) |
Peripheral vascular disease | 1 (3.3) |
Chronic kidney disease | 1 (3.3) |
Liver disease | 5 (16.7) |
Previous viral hepatitis (HBV/HCV) | 11 (36.7) |
Asthma | 1 (3.3) |
Neurologic disease | 4 (13.3) |
Gastrointestinal disease | 6 (20) |
Viro-immunologic parameters [median (IQR)] | |
CD4 T cell nadir, cells/µL | 277 (115–558) |
CD4 T cell percentage, % | 34 (28–39) |
CD4 T cell count, cells/µL | 790 (598–929) |
CD8 T cell percentage, % | 42 (36–48) |
CD8 T cell count, cells/µL | 952 (771–1151) |
CD4/CD8 ratio | 0.78 (0.59–1.1) |
HIV-RNA, copies/mL | <20 |
Previous AIDS diagnosis [n (%)] | 7 (23.3) |
Time from HIV diagnosis, months [median (IQR)] | 160 (85–259) |
Current ART regimen [n (%)] | |
INSTI-based triple | 16 (53.3) |
INSTI-based dual | 11 (36.7) |
NNRTI-based triple | 3 (10) |
Duration of ART, months [median (IQR)] | 134 (65–187) |
